scholarly article | Q13442814 |
P2093 | author name string | Soo Youn Lee | |
Jeong Yong Jeon | |||
Myung Ae Lee | |||
Kyung Gi Cho | |||
Jeung Hee An | |||
Seong U Kim | |||
P433 | issue | 6 | |
P304 | page(s) | 2873-2881 | |
P577 | publication date | 2009-06-01 | |
P1433 | published in | Journal of Proteome Research | Q3186939 |
P1476 | title | Identification of gliotropic factors that induce human stem cell migration to malignant tumor | |
P478 | volume | 8 |
Q38227489 | Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy |
Q36030236 | Altered carcinogenesis and proteome in mammary glands of rats after prepubertal exposures to the hormonally active chemicals bisphenol a and genistein |
Q34943738 | Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction. |
Q33695158 | CDK5-induced p-PPARγ(Ser 112) downregulates GFAP via PPREs in developing rat brain: effect of metal mixture and troglitazone in astrocytes. |
Q38374291 | COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression. |
Q98195540 | COL4A1 promotes the growth and metastasis of hepatocellular carcinoma cells by activating FAK-Src signaling |
Q34512617 | Contact and encirclement of glioma cells in vitro is an intrinsic behavior of a clonal human neural stem cell line |
Q89621221 | Extracellular Vesicles in Glioblastoma Tumor Microenvironment |
Q37592190 | Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. |
Q46295328 | Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model |
Q37423979 | In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion. |
Q38961107 | MIF Receptor CD74 is Restricted to Microglia/Macrophages, Associated with a M1-Polarized Immune Milieu and Prolonged Patient Survival in Gliomas |
Q58765729 | Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury |
Q35433358 | MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid β, novel targets in sporadic Alzheimer's disease |
Q34248372 | Molecular characterization of circumventricular organs and third ventricle ependyma in the rat: potential markers for periventricular tumors. |
Q45002880 | Moutan Cortex Radicis inhibits inflammatory changes of gene expression in lipopolysaccharide-stimulated gingival fibroblasts |
Q47930540 | Neural Precursor-Derived Pleiotrophin Mediates Subventricular Zone Invasion by Glioma |
Q33704489 | Neural stem cell therapy for cancer |
Q82605666 | Neuroprotective Changes of Striatal Degeneration-Related Gene Expression by Acupuncture in an MPTP Mouse Model of Parkinsonism: Microarray Analysis |
Q34476771 | Neuroprotective changes in degeneration-related gene expression in the substantia nigra following acupuncture in an MPTP mouse model of Parkinsonism: Microarray analysis |
Q38384375 | Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease. |
Q35170365 | Proteomics of gliomas: initial biomarker discovery and evolution of technology |
Q34758639 | Reverse engineering of modified genes by Bayesian network analysis defines molecular determinants critical to the development of glioblastoma |
Q37310051 | Sexual Dimorphism and Aging in the Human Hyppocampus: Identification, Validation, and Impact of Differentially Expressed Genes by Factorial Microarray and Network Analysis. |
Q26771835 | Stem cells as cellular vehicles for gene therapy against glioblastoma |
Q39014784 | TIMP-1 modulates chemotaxis of human neural stem cells through CD63 and integrin signalling |
Q38139120 | The potential for genetically altered microglia to influence glioma treatment. |
Q34217778 | The use of neural stem cells in cancer gene therapy: predicting the path to the clinic |
Q38213836 | Therapeutic cell carriers: a potential road to cure glioma |
Q38289649 | Tumor matrix protein collagen XIα1 in cancer |
Q37829108 | Using living cells to transport therapeutic genes for cancer treatment |
Q34581858 | Validation of COL11A1/procollagen 11A1 expression in TGF-β1-activated immortalised human mesenchymal cells and in stromal cells of human colon adenocarcinoma. |
Q98499768 | Vesiclemia: counting on extracellular vesicles for glioblastoma patients |
Q36947735 | p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair. |
Search more.